Charles Farkas Power - 29 May 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Reporting relationship: Director
Issuer ticker: CNMD
Reported as of: 29 May 2025
Net transaction value: -$28.54
SEC form: 4
Accepted by SEC: 30 May 2025, 17:12:08 UTC
Prior SEC filing: 06 May 2025
Next SEC filing: 04 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Thomas Fistek for Charles Farkas by Power of Attorney

Key filing fact

Charles Farkas Power filed Form 4 for CONMED Corp (CNMD) on 30 May 2025.

Key facts

This page summarizes Charles Farkas Power's Form 4 filing for CONMED Corp (CNMD).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 30 May 2025, 17:12.

Change

Previous filing in this sequence was filed on 06 May 2025.
Current net transaction value: -$28.54.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001615538 Primary reporting owner

Farkas Charles

Relationship: Director
Address: C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature: /s/ Thomas Fistek for Charles Farkas by Power of Attorney
Signature date: 30 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD transaction

Common Stock

Options Exercise

Transaction value: $55,700
Shares: +1,000
Change %: +6.1%
Price: $55.70
Shares after: 17,346
Date: 29 May 2025
Ownership: Direct

CNMD transaction

Common Stock

Tax liability

Transaction value: $55,729
Shares: -966
Change %: -5.6%
Price: $57.69
Shares after: 16,380
Date: 29 May 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

SARs (Stock Appreciation Rights)

Options Exercise

Transaction value: $0
Shares: -1,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000
Exercise price: $55.70
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.